Related Experiment Video
Updated: Aug 16, 2026

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
Published on: May 25, 2017
[Serine protease inhibitors prevent alcoholic liver injury]
Nobuyuki Enomoto1, Yoshiyuki Takei, Kazuyoshi Kon
1Department of Gastroenterology, School of Medicine, Juntendo University, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Abstract:
The hepatotoxic effects of alcohol have been described in detail, but factors responsible for its hepatotoxicity have only partially characterized. It now appears that Kupffer cell derived TNF-alpha participates in several aspects of alcoholic liver injury. On the other hand, protease inhibitors have been used successfully for treatment of intractable diseases in which TNF-alpha is involved in the pathogenesis, including ulcerative colitis and Crohn's disease. Here, we will review new evidence for the proposal that serine protease inhibitors prevents alcoholic liver injury via mechanisms dependent on Kupffer cell derived TNF-alpha.
Insights
Serine protease inhibitors may prevent alcohol-induced liver injury. This effect appears linked to Kupffer cell-derived tumor necrosis factor-alpha (TNF-alpha), a key factor in alcoholic liver disease.
Area of Science:
- Hepatology
- Immunology
- Pharmacology
Context:
- Alcoholic liver injury is a significant health concern with incompletely understood mechanisms.
- Kupffer cells and their derived tumor necrosis factor-alpha (TNF-alpha) are implicated in alcoholic liver pathogenesis.
- Protease inhibitors show therapeutic potential in inflammatory diseases involving TNF-alpha.
Purpose:
- To review evidence supporting the role of serine protease inhibitors in preventing alcoholic liver injury.
- To explore the mechanisms by which serine protease inhibitors might counteract alcohol-induced liver damage, focusing on TNF-alpha.
Summary:
- Alcohol consumption leads to liver damage, partly mediated by Kupffer cell-derived TNF-alpha.
- Serine protease inhibitors have a history of successful use in TNF-alpha-related inflammatory conditions.
- Emerging evidence suggests these inhibitors can prevent alcoholic liver injury through pathways involving Kupffer cell-derived TNF-alpha.
Impact:
- Highlights a potential therapeutic strategy for alcoholic liver disease.
- Suggests a mechanistic link between serine protease inhibitors, TNF-alpha, and liver protection.
- Provides a basis for further research into protease inhibitor-based treatments for alcohol-related liver conditions.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Enzyme Inhibition
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Protection of Alcohols
Protection
It defines a protecting group as the masking agent to make the more reactive species inert to a given set of conditions. This concept is depicted via the illustration of liquid flow through different outlets in an assembly of pipes. The analogy helps to understand the role...
Cirrhosis I: Introduction